Associated Papers
A Novel Gain-of-Function RAC2 Variant (p.Y64H) Associated With Lymphopenia and Leukopenia.
Haliloğlu Y et al.
Pediatric Blood & Cancer, 2026
Accurate affinity models for SH2 domains from peptide binding assays and free-energy regression.
Gagoski D et al.
Protein Science : a Publication of the Protein Society, 2025
41088778 (PubMed )
Supplement: PRO-34-e70317-s008.xlsx › _S6_-_PTMVar_-_Fyn
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.
Gagoski D et al.
Biorxiv : the Preprint Server for Biology, 2025
39764007 (PubMed )
Supplement: media-1.xlsx › _S6_-_PTMVar_-_Fyn
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
Zhang L et al.
Journal of Clinical Immunology, 2022
Transforming mutations of RAC guanosine triphosphatases in human cancers.
Kawazu M et al.
Proceedings of the National Academy of Sciences of the United States of America, 2013
RAC1P29S is a spontaneously activating cancer-associated GTPase.
Davis MJ et al.
Proceedings of the National Academy of Sciences of the United States of America, 2013
Select a paper to view details